GO
Loading...

Enter multiple symbols separated by commas

Drug Retail

More

  • Confidence Back? Several Retailers Top Sales Forecasts Thursday, 7 Mar 2013 | 8:39 AM ET

    After a difficult January, when shoppers first felt the effect of a payroll tax hike that lowered take-home pay by 2 percent, some retailers got a little relief in February from growing employment and a rising stock market.

  • Alex Gorsky

    Containing health care costs, promoting innovation and the treatment of deadly diseases are among the biggest challenges the U.S. faces, Johnson and Johnson CEO Alex Gorsky said on Thursday.

  • Indonesia Central Bank Shuffle Plan Raises Concern Monday, 4 Mar 2013 | 8:31 PM ET
    Pedestrians cross a street in Jakarta's modern business district.

    Moves by Indonesia's President Susilo Bambang Yudhoyono to put his finance minister in charge of the central bank is leading to concerns that he may be seeking someone more malleable to run the state coffers in the run up to next year's elections.

  • You Have to Love a Lucrative 'Drug Deal' Thursday, 28 Feb 2013 | 1:25 PM ET

    The pharmaceutical and biopharmaceutical sectors have been marching steadily higher. TheStreet.com reports on two stocks with potential to appreciate.

  • Mylan CEO on Earnings Beat Thursday, 28 Feb 2013 | 12:00 AM ET
    Mylan CEO on Earnings Beat

    Mylan's aquisition of Agila is expected to double its business. Heather Bresch, Myland CEO, offers insight.

  • USPS Takes Armstrong to Court Friday, 22 Feb 2013 | 1:41 PM ET
    USPS Takes Armstrong to Court

    CNBC's Brian Shactman reports the Department of Justice is joining Floyd Landis in a lawsuit accusing Lance Armstrong using performance-enhancing drugs while being sponsored by the U.S. Postal Service. Armstrong says he did not cost the government money. Instead, he says the Postal Service actually benefitted to the tune of more than $100 million from its association with the disgraced cyclist.

  • Global Fight Against Tuberculosis Friday, 22 Feb 2013 | 1:22 PM ET
    Global Fight Against Tuberculosis

    Turberculosis is making a global comeback, including in the United States. Dr. William Schaffner of Vanderbilt University School of Medicine, discusses the concern surrounding the disease.

  • Higher Taxes Put the Brakes on Retail Spending Wednesday, 13 Feb 2013 | 8:33 AM ET

    Retail sales barely rose in January as tax increases and higher gasoline prices restrained spending. Separately, import and export prices rose slightly less than expected in the month.

  • Help Wanted: Washington Weed Czar Wednesday, 30 Jan 2013 | 1:49 PM ET
    Help Wanted: Washington Weed Czar

    Washington State's liquor control board is seeking a marijuana consultant to help forge ahead regulation for its newly legalized substance. Steve Fox, director of government relations with the Marijuana Policy Project, offers insight.

  • Opko Health CEO on Cytochromas Acquisition Monday, 28 Jan 2013 | 6:15 PM ET
    Opko Health CEO on Cytochromas Acquisition

    Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.

  • Actavis CEO: Continue Seeking Opportunities In Emerging Markets

    Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.

  • Branding & Redemption Thursday, 17 Jan 2013 | 1:30 PM ET
    Branding & Redemption

    The world is gearing up for Lance Armstrong's big interview tonight with Oprah Winfrey. Robbie Vorhaus, founder & CEO of Vorhaus Communications, weighs in.

  • Talking Numbers: Drug War Heats Up Tuesday, 15 Jan 2013 | 3:30 PM ET
    Talking Numbers: Drug War Heats Up

    The relative prospects for shares of Pfizer and Johnson & Johnson are debated by a fundamental analyst and a technical analyst. (2:58)

  • CVS Changes the Way It Stocks Tylenol Tuesday, 15 Jan 2013 | 2:46 PM ET
    CVS Changes the Way It Stocks Tylenol

    In the wake of Johnson & Johnson's manufacturing problems, CVS has changed the way it stocks Tylenol, reports CNBC's Bertha Coombs.

  • Lance Armstrong Confesses Tuesday, 15 Jan 2013 | 1:44 PM ET
    Lance Armstrong Confesses

    NBC's Anne Thompson reports Lance Armstrong confessed to using performance enhancing drugs in an interview with Oprah Winfrey; and CNBC's Scott Cohn reports Armstrong has now complied with the subpoena for all of his medical records.

  • Breakthrough Watch: MS Drug Could Have Other Uses Wednesday, 9 Jan 2013 | 6:17 PM ET
    Health care

    Could a widely used MS treatment work on other diseases?

  • BioMarin's CEO On Its Product Pipeline Tuesday, 8 Jan 2013 | 2:20 PM ET
    BioMarin's CEO On Its Product Pipeline

    The iShare Biotech ETF is up 32 percent over the past year. Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses the reason behind his company behind up 24.9 percent in the last 3 months.

  • Death of Gift Cards? Tuesday, 8 Jan 2013 | 2:09 PM ET
    Barnes & Noble gift cards

    Retailers should be buzzing right now with holiday gift card redemptions. But, there's early evidence retailers aren't getting much of a boost from gift cards this year, according to NBG Market Analyst Brian Sozzi.

  • Onyx CEO on Partnership With Bayer Tuesday, 8 Jan 2013 | 1:22 PM ET
    Onyx CEO on Partnership With Bayer

    Onyx Pharmaceuticals CEO Dr. Anthony Coles discusses his company's thyroid cancer drug and its blood cancer drug and its partnership with Bayer.

  • NPS Pharmaceuticals CEO on Gattex's FDA Approval Monday, 7 Jan 2013 | 6:15 PM ET
    NPS Pharmaceuticals CEO on Gattex's FDA Approval

    NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.